DK0714394T3 - Antipsykotisk fremgangsmåde - Google Patents

Antipsykotisk fremgangsmåde

Info

Publication number
DK0714394T3
DK0714394T3 DK94924710T DK94924710T DK0714394T3 DK 0714394 T3 DK0714394 T3 DK 0714394T3 DK 94924710 T DK94924710 T DK 94924710T DK 94924710 T DK94924710 T DK 94924710T DK 0714394 T3 DK0714394 T3 DK 0714394T3
Authority
DK
Denmark
Prior art keywords
antipsychotic method
antipsychotic
schizophrenia
susceptible
treating
Prior art date
Application number
DK94924710T
Other languages
English (en)
Inventor
Franklin Porter Bymaster
Harlan E Shannon
Per Sauerberg
Preben H Olesen
John Stanley Ward
Charles H Mitch
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK0714394T3 publication Critical patent/DK0714394T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Epoxy Resins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
DK94924710T 1993-08-19 1994-08-18 Antipsykotisk fremgangsmåde DK0714394T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10928593A 1993-08-19 1993-08-19
PCT/DK1994/000309 WO1995005379A1 (en) 1993-08-19 1994-08-18 Antipsychotic method

Publications (1)

Publication Number Publication Date
DK0714394T3 true DK0714394T3 (da) 2001-10-01

Family

ID=22326851

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94924710T DK0714394T3 (da) 1993-08-19 1994-08-18 Antipsykotisk fremgangsmåde

Country Status (23)

Country Link
US (3) US5677313A (da)
EP (1) EP0714394B1 (da)
JP (1) JP3474575B2 (da)
KR (1) KR960703908A (da)
CN (1) CN1040979C (da)
AT (1) ATE202353T1 (da)
CA (1) CA2169838C (da)
CZ (1) CZ42796A3 (da)
DE (1) DE69427537T2 (da)
DK (1) DK0714394T3 (da)
ES (1) ES2160127T3 (da)
FI (1) FI960748A7 (da)
GR (1) GR3036587T3 (da)
HU (1) HU222116B1 (da)
IL (1) IL110727A (da)
NO (1) NO310597B1 (da)
NZ (2) NZ336596A (da)
PT (1) PT714394E (da)
SG (1) SG55072A1 (da)
TW (1) TW442285B (da)
UA (1) UA43347C2 (da)
WO (1) WO1995005379A1 (da)
ZA (1) ZA946321B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0714394T3 (da) * 1993-08-19 2001-10-01 Novo Nordisk As Antipsykotisk fremgangsmåde
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5672709A (en) * 1994-10-24 1997-09-30 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
PE17897A1 (es) * 1995-02-17 1997-06-12 Lilly Co Eli Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
US5763457A (en) * 1995-11-13 1998-06-09 Eli Lilly And Company Method for treating anxiety
AU1128297A (en) * 1995-12-06 1997-06-27 Eli Lilly And Company Composition for treating pain
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
JP2001520653A (ja) * 1997-04-11 2001-10-30 エリ リリー アンド カンパニー 精神分裂病の治療法
WO1998046227A1 (en) * 1997-04-11 1998-10-22 Eli Lilly And Company Composition for treating pain
US20040023951A1 (en) * 2001-06-18 2004-02-05 Bymaster Franklin Porter Combination therapy for treatment of psychoses
WO2009067579A1 (en) * 2007-11-21 2009-05-28 Abbott Laboratories Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
WO2009140483A1 (en) 2008-05-15 2009-11-19 University Of Toledo Muscarinic agonists as cognitive enhancers
US9549928B2 (en) 2011-04-29 2017-01-24 The University Of Toledo Muscarinic agonists as enhancers of cognitive flexibility

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2061502T3 (es) * 1986-06-27 1994-12-16 Beecham Group Plc Nuevos n-heterociclos biciclicos puenteados.
US4977176A (en) * 1987-01-31 1990-12-11 Sandoz Ltd. Pilocarpine compounds which are used as pharmaceutical agents
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK0714394T3 (da) * 1993-08-19 2001-10-01 Novo Nordisk As Antipsykotisk fremgangsmåde

Also Published As

Publication number Publication date
CN1040979C (zh) 1998-12-02
NO960620L (no) 1996-04-18
NO310597B1 (no) 2001-07-30
ZA946321B (en) 1996-02-19
SG55072A1 (en) 1998-12-21
US5679686A (en) 1997-10-21
HUT73854A (en) 1996-09-30
AU7490494A (en) 1995-03-14
HU9600363D0 (en) 1996-04-29
FI960748L (fi) 1996-04-18
IL110727A (en) 1998-08-16
EP0714394B1 (en) 2001-06-20
TW442285B (en) 2001-06-23
CN1133044A (zh) 1996-10-09
DE69427537D1 (de) 2001-07-26
NZ336596A (en) 2001-02-23
NZ271313A (en) 1999-09-29
ATE202353T1 (de) 2001-07-15
NO960620D0 (no) 1996-02-16
US5968926A (en) 1999-10-19
KR960703908A (ko) 1996-08-31
FI960748A7 (fi) 1996-04-18
CA2169838C (en) 2002-06-11
FI960748A0 (fi) 1996-02-19
ES2160127T3 (es) 2001-11-01
JP3474575B2 (ja) 2003-12-08
UA43347C2 (uk) 2001-12-17
US5677313A (en) 1997-10-14
EP0714394A1 (en) 1996-06-05
WO1995005379A1 (en) 1995-02-23
DE69427537T2 (de) 2002-04-04
HU222116B1 (hu) 2003-04-28
CZ42796A3 (en) 1996-12-11
CA2169838A1 (en) 1995-02-23
IL110727A0 (en) 1994-11-11
GR3036587T3 (en) 2001-12-31
JPH09501659A (ja) 1997-02-18
AU697529B2 (en) 1998-10-08
PT714394E (pt) 2001-12-28

Similar Documents

Publication Publication Date Title
DK0714394T3 (da) Antipsykotisk fremgangsmåde
NO944512L (no) Fremgangsmåte for behandling av oljebrönn
DE69421296D1 (de) Schmelzbehandlung
DE69401817D1 (de) Verbesserungen zum herstellen von glasartigem silika
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
DK0734259T3 (da) Antipsykotisk fremgangsmåde
NO953443D0 (no) Fremgangsmåte for behandling av fast avfall
DE69324427D1 (de) Neues endbehandlungsverfahren für hydroxyfunktionelle polythethern
NO942906L (no) Fremgangsmåte for oksydasjon av natriumsulfid
NO990450D0 (no) Behandling av sinnslidelser
NO941655D0 (no) Fremgangsmåte for detektering av sulfider
DE69419598D1 (de) Abstichverfahren für hochofen
FI933624A0 (fi) Apparat foer pappers- och kartongmaskin samt dess anvaendning
EP0653379A4 (en) Process for manufacturing homogeneous magnetite.
FR2706023B1 (fr) Programmeur analogique amélioré pour fours.
EP0713476A4 (en) Peroxide treatment process
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
ITTO930166A1 (it) Procedimento per il trattamento di flussi reflui della produzione di n-fosfonometilglicina.
KR970004363U (ko) 협잡물 처리용 원심분리기
ITMI932284A0 (it) Disolfuro chinolico
BR9304842A (pt) Processo de produção de ferro-gusa
FI931153A0 (fi) Anordning foer uppvaermning av stenmaterial
SE9304270D0 (sv) Process II
KR950009954U (ko) 브라운관 재생용 어닐링로
KR960024336U (ko) 유리제 난시용 안경렌즈